chr7-81950516-T-TA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_000722.4(CACNA2D1):c.3160-9_3160-8insT variant causes a splice polypyrimidine tract, intron change. The variant allele was found at a frequency of 0.0847 in 1,423,610 control chromosomes in the GnomAD database, including 2,403 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.075 ( 434 hom., cov: 31)
Exomes 𝑓: 0.086 ( 1969 hom. )
Consequence
CACNA2D1
NM_000722.4 splice_polypyrimidine_tract, intron
NM_000722.4 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.16
Genes affected
CACNA2D1 (HGNC:1399): (calcium voltage-gated channel auxiliary subunit alpha2delta 1) The preproprotein encoded by this gene is cleaved into multiple chains that comprise the alpha-2 and delta subunits of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. Mutations in this gene can cause cardiac deficiencies, including Brugada syndrome and short QT syndrome. Alternate splicing results in multiple transcript variants, some of which may lack the delta subunit portion. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 7-81950516-T-TA is Benign according to our data. Variant chr7-81950516-T-TA is described in ClinVar as [Benign]. Clinvar id is 215476.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0882 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CACNA2D1 | NM_000722.4 | c.3160-9_3160-8insT | splice_polypyrimidine_tract_variant, intron_variant | ENST00000356860.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CACNA2D1 | ENST00000356860.8 | c.3160-9_3160-8insT | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000722.4 | ||||
CACNA2D1 | ENST00000443883.2 | c.3196-9_3196-8insT | splice_polypyrimidine_tract_variant, intron_variant | 5 | P1 | ||||
CACNA2D1 | ENST00000705961.1 | c.2927-9_2927-8insT | splice_polypyrimidine_tract_variant, intron_variant | ||||||
CACNA2D1 | ENST00000705962.1 | c.3040-9_3040-8insT | splice_polypyrimidine_tract_variant, intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0745 AC: 10994AN: 147474Hom.: 433 Cov.: 31
GnomAD3 genomes
AF:
AC:
10994
AN:
147474
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0970 AC: 15541AN: 160184Hom.: 239 AF XY: 0.0949 AC XY: 8181AN XY: 86236
GnomAD3 exomes
AF:
AC:
15541
AN:
160184
Hom.:
AF XY:
AC XY:
8181
AN XY:
86236
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0858 AC: 109545AN: 1276046Hom.: 1969 Cov.: 31 AF XY: 0.0851 AC XY: 54004AN XY: 634724
GnomAD4 exome
AF:
AC:
109545
AN:
1276046
Hom.:
Cov.:
31
AF XY:
AC XY:
54004
AN XY:
634724
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0746 AC: 11009AN: 147564Hom.: 434 Cov.: 31 AF XY: 0.0733 AC XY: 5262AN XY: 71820
GnomAD4 genome
AF:
AC:
11009
AN:
147564
Hom.:
Cov.:
31
AF XY:
AC XY:
5262
AN XY:
71820
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 12, 2018 | - - |
Brugada syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at